Sudden Infant Death Syndrome Linked to Unusual Metabolite Levels: Study

Newborn screening may hold the key to SIDS prevention. Experts also share other prevention methods.

morrowlight/Shutterstock

Researchers have identified 14 biomarkers that, if atypical at birth, may increase an infant’s risk of sudden infant death syndrome, or SIDS—a fatal syndrome that has long puzzled doctors.

The study evaluated more than 350 infants who died from SIDS and compared them to more than 1,400 babies who were not stricken by the syndrome.